Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P- Y Dietrich

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
International Immunology|July 28, 1999
Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subsetG Perrin, V Schnuriger, A L Quiquerez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocolsS Bodis, M Henry-Amar, J Bosq, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Immunity|October 6, 2000
Soluble CD86 is a costimulatory molecule for human T lymphocytesP Jeannin, G Magistrelli, J P Aubry, et al.
The Journal of Clinical Investigation|March 15, 1997
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?P Saas, P R Walker, M Hahne, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
The Journal of Pathology|March 9, 2006
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomasB Jenny, J A Harrison, D Baetens, et al.
British Journal of Cancer|May 3, 2014
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
British Journal of Cancer|January 10, 2018
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
Cancer Research|August 2, 2001
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activityV Dutoit, V Rubio-Godoy, P Y Dietrich, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
International Immunology|July 28, 1999
Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subsetG Perrin, V Schnuriger, A L Quiquerez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Late relapse in early-stage Hodgkin's disease patients enrolled on European Organization for Research and Treatment of Cancer protocolsS Bodis, M Henry-Amar, J Bosq, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
Immunity|October 6, 2000
Soluble CD86 is a costimulatory molecule for human T lymphocytesP Jeannin, G Magistrelli, J P Aubry, et al.
The Journal of Clinical Investigation|March 15, 1997
Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?P Saas, P R Walker, M Hahne, et al.
Advances in Experimental Medicine and Biology|February 23, 1999
Gene therapy with cytokine-transfected xenogeneic cells in metastatic tumorsC F Rochlitz, P Jantscheff, G Bongartz, et al.
The Journal of Pathology|March 9, 2006
Expression and localization of VEGF-C and VEGFR-3 in glioblastomas and haemangioblastomasB Jenny, J A Harrison, D Baetens, et al.
British Journal of Cancer|May 3, 2014
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
British Journal of Cancer|January 10, 2018
Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade gliomaA F Hottinger, A Ben Aissa, V Espeli, et al.
Cancer Research|August 2, 2001
Heterogeneous T-cell response to MAGE-A10(254-262): high avidity-specific cytolytic T lymphocytes show superior antitumor activityV Dutoit, V Rubio-Godoy, P Y Dietrich, et al.
Pageof 10